Eugia recalls one lot of vancomycin injection to the hospital level for glass particulate
Published November 15, 2026 · Coverage November 8–14, 2026, Pacific · High priority
Eugia US LLC announced on November 6, 2026 a voluntary nationwide recall, to the hospital/healthcare facility/user level, of one lot (3VM26026A) of Vancomycin Hydrochloride for Injection USP (United States Pharmacopeia) 1.25g/Vial-30mL because a glass particle was found inside a vial; FDA posted the announcement on November 9, 2026. The lot shipped to wholesalers nationwide from September 2 through September 15, 2026, and holders are told to discontinue use and quarantine it immediately.

Current status
On November 15, 2026, FDA's posting of the Eugia announcement still showed content current as of November 9, 2026, and FDA's drug enforcement records (openFDA) returned no Eugia record with a report date from October 1 through November 15, 2026, so this check did not establish an FDA recall classification. FDA's MedWatch feed listed no later item on the recall.
Who this affects
Hospitals, health-system pharmacies and infusion sites holding Eugia vancomycin hydrochloride for injection 1.25 g vials, lot 3VM26026A.
Why it matters
The company says there is a reasonable probability that use of product containing glass particulates can cause serious adverse health consequences such as blockage and clotting in blood vessels, with greater susceptibility in neonates, infants and patients with compromised organ function. Inference: any unit of lot 3VM26026A still in a pharmacy, satellite or automated cabinet remains a patient-safety exposure until it is quarantined and returned.
Required actions
- None stated as a legal requirement; the company announcement directs holders of the lot to discontinue use and quarantine immediately (2026-11-06 announcement).
Recommended action
- Search all pharmacy locations and cabinets for lot 3VM26026A and quarantine
- Inform clinicians of the recall as the announcement asks
- Document the recall response in the drug recall log
Scope and timing
- Authority status
- Other (company-initiated voluntary recall announcement posted by FDA)
- Responsible owner
- Pharmacy
- Publication date
- 2026-11-09 (FDA publish date)
- Other dates
- 2026-11-06 company announcement date; lot shipped 2026-09-02 to 2026-09-15
Not established
FDA recall classification not established.
Earlier article: November 8, 2026 edition →
Sources
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Compliance Sweep report →